1-3 of 3
Kapil Saxena, MD, MS
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Bay 81-8973 Prophylaxis Frequency and Long-Term Bleed Outcomes in the Leopold I Extension Study

Kapil Saxena, MD MS, Gautam Sajeev, ScD, Rajeev Ayyagari, PhD, Akanksha Dua, BA, Nikki Church, MD MBA, Martin Sanabria, MD, Olubunmi O. Afonja, MD MBA
Journal: Blood
Blood (2017) 130 (Supplement 1): 1076.
https://doi.org/10.1182/blood.V130.Suppl_1.1076.1076
Published: 2017
Journal Articles

Absence of Inhibitor Development in the Routine Clinical Use of Alphanate ® in Patients with Severe Hemophilia A: Results From a Long-Term Post-Marketing Surveillance Study.

Charles L. Sexauer, MD, Yasmin Ayob, Madeline Cantini, Miguel Antonio Escobar, MD, Tamiko Fukuda, Kristine Holtz, Pier Manucci, Kathryn Moynihan, Kapil Saxena, MD, MS, Christopher Walsh, MD, PhD, Antonio Páez, Paul P Pinciaro, Michael Ken Woodward
Journal: Blood
Blood (2009) 114 (22): 3141.
https://doi.org/10.1182/blood.V114.22.3141.3141
Published: 2009
Journal Articles

Universal Thrombophilia Screening with Risk Stratification and Anticoagulation Management in Pediatric Renal Transplant Recipients.

Kapil Saxena, MD, MS, Martin Turman, MD, Rene Y. McNall-Knapp, MD, Pornpimol Rianthavorn, MD, Bradley P. Kropp, MD, Puneet Sindhwani, MD, William H. Meyer, MD
Journal: Blood
Blood (2007) 110 (11): 4011.
https://doi.org/10.1182/blood.V110.11.4011.4011
Published: 2007